HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses].

Abstract
Piretanide is a new diuretic agent that is structurally related to bumetanide and furosemide. The effect of a single oral dose of piretanide 12 mg on the serum agent levels and diuretic activity was compared with that of Furosemide 80 mg p.o. in 12 patients with advanced renal insufficiency using a balanced randomized design. Piretanide was seen to have its most pronounced activity in the 1st h, while the effect of furosemide was more prolonged without abrupt peaks. There was a tendency of water conservation following the diuresis with piretanide, which produced a lesser response in volume and sodium excretion than furosemide when analysed as cumulative excretion at 24 h. The sodium-potassium ratio of the total urinary volume increased slightly by the same amount. Piretanide was approximately 5 times more potent on a weight basis than furosemide. Piretanide appeared to be effective in advanced renal insufficiency. Due to its rapid elimination effect piretanide as well as furosemide is also indicated for the treatment of renal edema in emergency situations.
AuthorsL J Heuer, H Machnik, J Studt, R Fink
JournalArzneimittel-Forschung (Arzneimittelforschung) Vol. 33 Issue 9 Pg. 1318-21 ( 1983) ISSN: 0004-4172 [Print] Germany
Vernacular TitleKlinische Vergleichsprüfung von Piretanid und Furosemid bei Patienten mit fortgeschrittener Niereninsuffizienz. Wirkstoffspiegel und diuretische Potenz einer oralen Einzeldosis.
PMID6685516 (Publication Type: Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Diuretics
  • Electrolytes
  • Sulfonamides
  • Furosemide
  • Creatinine
  • piretanide
Topics
  • Aged
  • Creatinine (metabolism)
  • Diuretics (blood, therapeutic use)
  • Electrolytes (metabolism)
  • Female
  • Furosemide (blood, therapeutic use)
  • Humans
  • Kidney Diseases (drug therapy, metabolism)
  • Male
  • Middle Aged
  • Sulfonamides (blood, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: